Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$326,138
+$289,254 QoQ
Shares Held
32,910
+447.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#73
of 183 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Derivatives in DNA
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
864
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GROUP ONE TRADING LLC holds $113,693,049 across 200 Biotechnology names. DNA ranks #50 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
203,915 | $14,280,167 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
261,443 | $10,198,891 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
272,609 | $6,564,424 | |
| 4 | ABSI |
Absci Corp
|
524,747 | $6,081,817 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
151,994 | $5,640,497 | |
| 6 | NKTR |
Nektar Therapeutics
|
70,371 | $4,912,599 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
85,040 | $4,638,081 | |
| 8 | ABVX |
Abivax S.A.
|
29,767 | $3,966,750 |
All Filings in DNA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,138 | 32,910 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $36,884 | 6,017 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $120,154 | 14,459 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $88,704 | 6,084 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $609,291 | 62,046 | Shares | Sole | 2025-05-14 | |
| 2024-06-30 DNABW | — | 864 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $386,203 | 1,156,299 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 DNABW | — | 864 | Call | Sole | 2024-05-10 | |
| 2024-03-31 | $1,068,554 | 921,168 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 DNABW | — | 864 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $586,546 | 347,069 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 DNABW | — | 864 | Call | Sole | 2023-11-09 | |
| 2023-09-30 | $659,437 | 364,330 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $321,337 | 172,762 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $233,734 | 175,740 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $382,653 | 226,422 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $497,081 | 159,321 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $766,681 | 322,135 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||